시간 외 거래: 4.99 0.27 +5.72%

Champions Oncology Inc (CSBR)

Champions Oncology Inc 주식(CSBR)의 최신 뉴스

Champions Oncology Inc (CSBR)

Champions Oncology Inc 주식(CSBR)의 최신 뉴스

Patient Derived Xenograft or PDX Models Market Growth Factors & Key Statistics - Economica

Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business - Yahoo Finance

Magnetar Financial LLC Buys Shares of 2,193,929 ChampionX Co. (NASDAQ:CHX) - Defense World

Its Stock Has Paid Off Big Time For Champion Homes Inc. - SETE News

P Schoenfeld Asset Management LP Makes New $5.45 Million Investment in ChampionX Co. (NASDAQ:CHX) - Defense World

Potential Price Increase for Champion Homes Inc. (SKY) After Recent Insider Activity - Knox Daily

Ameritas Investment Partners Inc. Has $1.97 Million Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World

DekaBank Deutsche Girozentrale Makes New Investment in ChampionX Co. (NASDAQ:CHX) - Defense World

Renaissance Technologies LLC Takes Position in ChampionX Co. (NASDAQ:CHX) - MarketBeat

Benjamin Edwards Inc. Increases Stake in ChampionX Co. (NASDAQ:CHX) - Defense World

622,616 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Renaissance Technologies LLC - Defense World

CHX Shares Experience Surge in Value - Knox Daily

6,878 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Choreo LLC - Defense World

ChampionX Co. (NASDAQ:CHX) Shares Sold by Oppenheimer Asset Management Inc. - Defense World

Seven Eight Capital LP Acquires Shares of 56,674 ChampionX Co. (NASDAQ:CHX) - Defense World

Mutual of America Capital Management LLC Sells 237,847 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World

Victory Capital Management Inc. Sells 56,930 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World

State of New Jersey Common Pension Fund D Trims Stake in ChampionX Co. (NASDAQ:CHX) - Defense World

Meeder Advisory Services Inc. Has $217,000 Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World

Tumor Mice Model Market Detailed Summary, Industry Size and Future Growth Prospects To 2024-2032 - Cauverynews

Local official champions Blood Cancer Awareness Month to boost education - WTOV Steubenville

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - MSN

Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday - MSN

Champions Oncology upgraded to buy by Craig-Hallum - MSN

What is CSBR’s price-to-sales ratio telling us about the company’s value? - US Post News

Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 By Investing.com - Investing.com Australia

Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews

Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript - Insider Monkey

Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 - Investing.com India

Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 - Investing.com

Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 By Investing.com - Investing.com UK

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday - Benzinga

Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2024 - Marketscreener.com

Stocks to Watch: Oxford Industries, Mobile Infrastructure, Champions Oncology - MarketWatch

Champions Oncology Shares Jump After Swinging to Profit, Posting Higher Revenue in 1Q - MarketWatch

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - wallstreet:online

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - StockTitan

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - Yahoo Finance

CSBR stock touches 52-week low at $3.94 amid market challenges - Investing.com

CSBR stock touches 52-week low at $3.94 amid market challenges - Investing.com UK

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - StockTitan

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - Yahoo Finance

Champions Oncology (NASDAQ:CSBR investor three-year losses grow to 58% as the stock sheds US$8.0m this past week - Simply Wall St

Patient Derived Xenograft (PDX) Models Market Projected Growth Outlined by Size, Share And Trends Report 20... - WhaTech

Champions of Health Care 2024: CHI Memorial Hospital - Chattanooga Times Free Press

CSBR stock touches 52-week low at $3.96 amid market challenges - Investing.com

Patient Derived Xenograft or PDX Models Market Business Insights, Key Trend Analysis - Economica

CSBR stock touches 52-week low at $4.42 amid market challenges - Investing.com Australia

CSBR stock touches 52-week low at $4.42 amid market challenges - Investing.com India

GUIDE DOGS FOR THE BLIND CALIFORNIA CAMPUS TOURS PROVIDE A PEEK INTO HOW A GUIDE DOG IS TRAINED - Diablo Magazine

This Champions Oncology Insider Increased Their Holding By 14% Last Year - Yahoo Finance

Patient Derived Xenograft Model Market to See Booming Growth - openPR

CSBR stock touches 52-week low at $4.49 amid market challenges - Investing.com India

CSBR stock touches 52-week low at $4.49 amid market challenges - Investing.com Australia

CSBR stock touches 52-week low at $4.49 amid market challenges - Investing.com Canada

CSBR stock touches 52-week low at $4.49 amid market challenges - Investing.com

Drug Discovery and Preclinical CRO Market 2024 Key Insights - Economica

Before the Olympics were smoke-free, tobacco brand deals ran rampant - The Cancer Letter

OPINION | Carin Schoppmeyer: Challenge champions go glamping; Group embarks on $6.2 million campaign - Arkansas Online

Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Champions Oncology reports mixed FY2024 results - Investing.com

CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 - InvestorPlace

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript - Seeking Alpha

Earnings call: Champions Oncology reports mixed FY2024 results - Investing.com India

Champions Oncology Reports Quarterly Revenue of $14.0 Million - AccessWire

Champions Oncology Reports Quarterly Revenue of $14.0 Million - StockTitan

CSBR과 유사한 종목